252 related articles for article (PubMed ID: 28707202)
1. Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review.
Yao C; Bernstein LJ; Rich JB
Breast Cancer Res Treat; 2017 Nov; 166(1):15-28. PubMed ID: 28707202
[TBL] [Abstract][Full Text] [Related]
2. Cognitive impairment following chemotherapy for breast cancer: The impact of practice effect on results.
Cerulla N; Arcusa À; Navarro JB; de la Osa N; Garolera M; Enero C; Chico G; Fernández-Morales L
J Clin Exp Neuropsychol; 2019 Apr; 41(3):290-299. PubMed ID: 30477390
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy-induced cognitive impairment in breast cancer survivors: A systematic review of studies from 2000 to 2021.
Amani O; Mazaheri MA; Moghani MM; Zarani F; Choolabi RH
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1989. PubMed ID: 38351543
[TBL] [Abstract][Full Text] [Related]
4. Clearing the fog: a review of the effects of dietary omega-3 fatty acids and added sugars on chemotherapy-induced cognitive deficits.
Orchard TS; Gaudier-Diaz MM; Weinhold KR; Courtney DeVries A
Breast Cancer Res Treat; 2017 Feb; 161(3):391-398. PubMed ID: 27933449
[TBL] [Abstract][Full Text] [Related]
5. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence and characteristics of chemotherapy-related cognitive impairment in patients with breast cancer].
Park JH; Bae SH; Jung YS; Jung YM
J Korean Acad Nurs; 2015 Feb; 45(1):118-28. PubMed ID: 25743740
[TBL] [Abstract][Full Text] [Related]
7. Dissociation of decision making under ambiguity and decision making under risk in breast cancer patients receiving adjuvant chemotherapy: a neuropsychological study.
Chen X; Zhu C; Li J; Qiu L; Zhang L; Yu F; Ye R; Zhang J; Wang K
Brain Res; 2013 Oct; 1533():63-72. PubMed ID: 23954744
[TBL] [Abstract][Full Text] [Related]
8. Subjective and objective cognitive functioning among patients with breast cancer: effects of chemotherapy and mood symptoms.
Hsu YH; Chen VC; Hsieh CC; Weng YP; Hsu YT; Hsiao HP; Wang WK; Chen HM; Weng JC; Wu SI; Gossop M
Breast Cancer; 2021 Jan; 28(1):236-245. PubMed ID: 33030667
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.
Jim HS; Phillips KM; Chait S; Faul LA; Popa MA; Lee YH; Hussin MG; Jacobsen PB; Small BJ
J Clin Oncol; 2012 Oct; 30(29):3578-87. PubMed ID: 22927526
[TBL] [Abstract][Full Text] [Related]
10. Long-term cognitive impairment of breast cancer patients after chemotherapy: A functional MRI study.
Miao H; Li J; Hu S; He X; Partridge SC; Ren J; Bian Y; Yu Y; Qiu B
Eur J Radiol; 2016 Jun; 85(6):1053-7. PubMed ID: 27161051
[TBL] [Abstract][Full Text] [Related]
11. Therapies for Cognitive Deficits Associated With Chemotherapy for Breast Cancer: A Systematic Review of Objective Outcomes.
Morean DF; O'Dwyer L; Cherney LR
Arch Phys Med Rehabil; 2015 Oct; 96(10):1880-97. PubMed ID: 26026579
[TBL] [Abstract][Full Text] [Related]
12. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
13. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
[TBL] [Abstract][Full Text] [Related]
14. Impairment of the executive function in breast cancer patients receiving chemotherapy treatment: a functional MRI study.
Tao L; Lin H; Yan Y; Xu X; Wang L; Zhang J; Yu Y
Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 27436790
[TBL] [Abstract][Full Text] [Related]
15. Breast cancer plus adjuvant chemotherapy- related cognitive impairment: a case study.
Fischer B
Neurocase; 2019; 25(3-4):138-144. PubMed ID: 31237172
[TBL] [Abstract][Full Text] [Related]
16. Therapies for cognitive impairment in breast cancer survivors treated with chemotherapy: A protocol for systematic review.
Zhang Q; Gao X; Liu S; Yu L; Zhu J; Qiu S
Medicine (Baltimore); 2020 May; 99(19):e20092. PubMed ID: 32384481
[TBL] [Abstract][Full Text] [Related]
17. Analysis of memory deficits following chemotherapy in breast cancer survivors: evidence from the doors and people test.
Prokasheva S; Faran Y; Cwikel J; Geffen DB
J Psychosoc Oncol; 2011; 29(5):499-514. PubMed ID: 21882931
[TBL] [Abstract][Full Text] [Related]
18. Selective impairment of attention networks in breast cancer patients receiving chemotherapy treatment.
Chen X; Li J; Ren J; Hu X; Zhu C; Tian Y; Hu P; Ma H; Yu F; Wang K
Psychooncology; 2014 Oct; 23(10):1165-71. PubMed ID: 24737580
[TBL] [Abstract][Full Text] [Related]
19. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
Jung MS; Cimprich B
Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
[TBL] [Abstract][Full Text] [Related]
20. Does walking protect against decline in cognitive functioning among breast cancer patients undergoing chemotherapy? Results from a small randomised controlled trial.
Gokal K; Munir F; Ahmed S; Kancherla K; Wallis D
PLoS One; 2018; 13(11):e0206874. PubMed ID: 30485297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
